Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1981 Apr;45(4):376–384. doi: 10.1136/hrt.45.4.376

Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure.

B M Massie, B Kramer, E Shen, F Haughom
PMCID: PMC482537  PMID: 7225252

Abstract

Several reports have suggested that because isosorbide dinitrate and hydralazine have different and additive haemodynamic effects at rest in patients with chronic heart failure, these agents should be administered in combination. Some studies, however, indicate thay they are effective individually as well. Since most patients with heart failure are symptomatic only with activity, we examined the haemodynamic effects of these drugs given individually and in combination, at rest and during upright bicycle exercise. As has been noted previously, at rest isosorbide significantly lowered both ventricular filling pressures and did not change cardiac output; hydralazine increased cardiac output and had only a slight effect on pulmonary capillary wedge pressure; combined treatment produced both beneficial effects. In contrast, during exercise isosorbide dinitrate also raised cardiac output while hydralazine more dramatically lowered the wedge pressure. Combined treatment produced significantly greater improvement in each haemodynamic index than either drug alone, with a resulting 54 per cent increase in exercise cardiac output, and a 33 per cent reduction in exercise wedge pressure. Maximal oxygen consumption increased acutely during combined treatment. These findings suggest that isosorbide dinitrate and hydralazine may each be effective in some patients, but that they are even more beneficial in combination.

Full text

PDF
376

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnold S. B., Williams R. L., Ports T. A., Baughman R. A., Benet L. Z., Parmley W. W., Chatterjee K. Attenuation of prazosin effect on cardiac output in chronic heart failure. Ann Intern Med. 1979 Sep;91(3):345–349. doi: 10.7326/0003-4819-91-3-345. [DOI] [PubMed] [Google Scholar]
  2. Aronow W. S., Lurie M., Turbow M., Whittaker K., Van Camp S., Hughes D. Effect of prazosin vs placebo on chronic left ventricular heart failure. Circulation. 1979 Feb;59(2):344–350. doi: 10.1161/01.cir.59.2.344. [DOI] [PubMed] [Google Scholar]
  3. Awan N. A., Miller R. R., DeMaria A. N., Maxwell K. S., Neumann A., Mason D. T. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography. Circulation. 1977 Sep;56(3):346–354. doi: 10.1161/01.cir.56.3.346. [DOI] [PubMed] [Google Scholar]
  4. Chatterjee K., Parmley W. W., Massie B., Greenberg B., Werner J., Klausner S., Norman A. Oral hydralazine therapy for chronic refractory heart failure. Circulation. 1976 Dec;54(6):879–883. doi: 10.1161/01.cir.54.6.879. [DOI] [PubMed] [Google Scholar]
  5. Chatterjee K., Parmley W. W. The role of vasodilator therapy in heart failure. Prog Cardiovasc Dis. 1977 Jan-Feb;19(4):301–325. doi: 10.1016/0033-0620(77)90006-8. [DOI] [PubMed] [Google Scholar]
  6. Cohn J. N., Franciosa J. A. Vasodilator therapy of cardiac failure: (first of two parts). N Engl J Med. 1977 Jul 7;297(1):27–31. doi: 10.1056/NEJM197707072970105. [DOI] [PubMed] [Google Scholar]
  7. Elkayam U., Lejemtel T. H., Mathur M., Ribner H. S., Frishman W. H., Strom J., Sonnenblick E. H. Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure. Am J Cardiol. 1979 Sep;44(3):540–545. doi: 10.1016/0002-9149(79)90409-0. [DOI] [PubMed] [Google Scholar]
  8. Fitchett D. H., Neto J. A., Oakley C. M., Goodwin J. F. Hydralazine in the management of left ventricular failure. Am J Cardiol. 1979 Aug;44(2):303–309. doi: 10.1016/0002-9149(79)90321-7. [DOI] [PubMed] [Google Scholar]
  9. Franciosa J. A., Cohn J. N. Effect of isosorbide dinitrate on response to submaximal and maximal exercise in patients with congestive heart failure. Am J Cardiol. 1979 May;43(5):1009–1014. doi: 10.1016/0002-9149(79)90368-0. [DOI] [PubMed] [Google Scholar]
  10. Franciosa J. A., Cohn J. N. Immediate effects of hydralazine-isosorbide dinitrate combination on exercise capacity and exercise hemodynamics in patients with left ventricular failure. Circulation. 1979 Jun;59(6):1085–1091. doi: 10.1161/01.cir.59.6.1085. [DOI] [PubMed] [Google Scholar]
  11. Franciosa J. A., Cohn J. N. Sustained hemodynamic effects without tolerance during long-term isosorbide dinitrate treatment of chronic left ventricular failure. Am J Cardiol. 1980 Mar;45(3):648–654. doi: 10.1016/s0002-9149(80)80018-x. [DOI] [PubMed] [Google Scholar]
  12. Franciosa J. A., Mikulic E., Cohn J. N., Jose E., Fabie A. Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure. Circulation. 1974 Nov;50(5):1020–1024. doi: 10.1161/01.cir.50.5.1020. [DOI] [PubMed] [Google Scholar]
  13. Franciosa J. A., Nordstrom L. A., Cohn J. N. Nitrate therapy for congestive heart failure. JAMA. 1978 Aug 4;240(5):443–446. [PubMed] [Google Scholar]
  14. Franciosa J. A., Pierpont G., Cohn J. N. Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients. Ann Intern Med. 1977 Apr;86(4):388–393. doi: 10.7326/0003-4819-86-4-388. [DOI] [PubMed] [Google Scholar]
  15. Gelberg H. J., Rubin S. A., Ports T. A., Brundage B. H., Parmley W. W., Chatterjee K. Detection of left ventricular functional reserve by supine exercise hemodynamics in patients with severe, chronic heart failure. Am J Cardiol. 1979 Nov;44(6):1062–1067. doi: 10.1016/0002-9149(79)90170-x. [DOI] [PubMed] [Google Scholar]
  16. Gray R., Chatterjee K., Vyden J. K., Ganz W., Forrester J. S., Swan H. J. Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure. Am Heart J. 1975 Sep;90(3):346–352. doi: 10.1016/0002-8703(75)90324-5. [DOI] [PubMed] [Google Scholar]
  17. Guiha N. H., Cohn J. N., Mikulic E., Franciosa J. A., Limas C. J. Treatment of refractory heart failure with infusion of nitroprusside. N Engl J Med. 1974 Sep 19;291(12):587–592. doi: 10.1056/NEJM197409192911201. [DOI] [PubMed] [Google Scholar]
  18. Hindman M. C., Slosky D. A., Peter R. H., Newman G. E., Jones R. H., Wallace A. G. Rest and exercise hemodynamic effects of oral hydralazine in patients with coronary artery disease and left ventricular dysfunction. Circulation. 1980 Apr;61(4):751–758. doi: 10.1161/01.cir.61.4.751. [DOI] [PubMed] [Google Scholar]
  19. Massie B., Chatterjee K., Werner J., Greenberg B., Hart R., Parmley W. W. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure. Am J Cardiol. 1977 Nov;40(5):794–801. doi: 10.1016/0002-9149(77)90199-0. [DOI] [PubMed] [Google Scholar]
  20. Massie B., Ports T., Chatterjee K., Parmley W., Ostland J., O'Young J., Haughom F. Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements. Circulation. 1981 Feb;63(2):269–278. doi: 10.1161/01.cir.63.2.269. [DOI] [PubMed] [Google Scholar]
  21. Mehta J., Pepine C. J., Conti C. R. Haemodynamic effects of hydrallazine and of hydrallazine plus glyceryl trinitrate paste in heart failure. Br Heart J. 1978 Aug;40(8):845–850. doi: 10.1136/hrt.40.8.845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Miller R. R., Awan N. A., Maxwell K. S., Mason D. T. Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin. N Engl J Med. 1977 Aug 11;297(6):303–307. doi: 10.1056/NEJM197708112970604. [DOI] [PubMed] [Google Scholar]
  23. Miller R. R., Vismara L. A., Williams D. O., Amsterdam E. A., Mason D. T. Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation. Circ Res. 1976 Jul;39(1):127–133. doi: 10.1161/01.res.39.1.127. [DOI] [PubMed] [Google Scholar]
  24. Miller R. R., Vismara L. A., Zelis R., Amsterdam E. A., Mason D. T. Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance. Circulation. 1975 Feb;51(2):328–336. doi: 10.1161/01.cir.51.2.328. [DOI] [PubMed] [Google Scholar]
  25. Packer M., Meller J., Gorlin R., Herman M. V. Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure. Circulation. 1979 Mar;59(3):531–539. doi: 10.1161/01.cir.59.3.531. [DOI] [PubMed] [Google Scholar]
  26. Pierpont G. L., Cohn J. N., Franciosa J. A. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside. Chest. 1978 Jan;73(1):8–13. doi: 10.1378/chest.73.1.8. [DOI] [PubMed] [Google Scholar]
  27. Rubin S. A., Chatterjee K., Gelberg H. J., Ports T. A., Brundage B. H., Parmley W. W. Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure. Am J Cardiol. 1979 Apr;43(4):810–815. doi: 10.1016/0002-9149(79)90082-1. [DOI] [PubMed] [Google Scholar]
  28. Rubin S. A., Chatterjee K., Ports T. A., Gelberg H. J., Brundage B. H., Parmley W. W. Influence of short-term oral hydralazine therapy on exercise hemodynamics in patients with severe chronic heart failure. Am J Cardiol. 1979 Nov;44(6):1183–1189. doi: 10.1016/0002-9149(79)90186-3. [DOI] [PubMed] [Google Scholar]
  29. Severinghaus J. W. Blood gas calculator. J Appl Physiol. 1966 May;21(3):1108–1116. doi: 10.1152/jappl.1966.21.3.1108. [DOI] [PubMed] [Google Scholar]
  30. Stephens J., Camm J., Spurrell R. Improvement in exercise haemodynamics by isosorbide dinitrate in patients with severe congestive cardiac failure secondary to ischaemic heart disease. Br Heart J. 1978 Aug;40(8):832–837. doi: 10.1136/hrt.40.8.832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Taylor W. R., Forrester J. S., Magnusson P., Takano T., Chatterjee K., Swan H. J. Hemodynamic effects of nitroglycerin ointment in congestive heart failure. Am J Cardiol. 1976 Oct;38(4):469–473. doi: 10.1016/0002-9149(76)90465-3. [DOI] [PubMed] [Google Scholar]
  32. Williams D. O., Bommer W. J., Miller R. R., Amsterdam E. A., Mason D. T. Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effectiveness of isosorbide dinitrate. Am J Cardiol. 1977 Jan;39(1):84–90. doi: 10.1016/s0002-9149(77)80016-7. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES